-

Shoulder Surgeons Perform First U.S. Surgeries Using Exactech’s Next Generation Cage Glenoid

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced successful first surgeries using the Equinoxe® Laser Cage Glenoid, an innovative, next-generation shoulder implant designed to improve glenoid fixation in anatomic total shoulder arthroplasty.

This new glenoid implant, available in standard and augmented options, features a central bone cage and three peripheral cage pegs. Each cage peg is titanium, porous and 3D-printed. First surgeries were performed by Bradley Schoch, MD, of the Mayo Clinic (Jacksonville, Fla.), and Sean Grey, MD, of the Orthopaedic & Spine Center of the Rockies (Fort Collins, Colo.) – two of the product’s design surgeons.

Exactech’s manufacturing process for the Laser Cage Glenoid is unique. Its 3D-printed cage pegs are directly molded to the backside of the ultra-high molecular weight polyethylene (UHMWPE) articular surface, so there is no mechanical locking mechanism. Preclinical testing demonstrated the device successfully withstood cyclic loading at 3,750N (~850lbs) when implanted 5mm proud (simulating a glenoid that is not fully seated) - an extreme loading magnitude and configuration relative to industry standards.1*

“I am impressed by the mechanical strength1* of this unique hybrid design. Mechanical bench testing has demonstrated the remarkable strength of the 3D-printed porous cage pegs, which offer the potential for bone through-growth and better fixation relative to all-polyethylene glenoids,” said Dr. Grey.

The Laser Cage Glenoid builds upon the foundation of the original cage glenoid design, which has been clinically available since 2011. Clinical studies on Exactech’s original cage glenoid have shown that its titanium pegs are associated with a four-fold reduction in the occurrence of radiolucent glenoid lines, as compared to all-polyethylene cemented peg glenoid designs.2 Additionally, the cage glenoid’s wedge augmented design requires less glenoid reaming and preserves more bone than step-augmented glenoid designs.3*

“The Laser Cage Glenoid is provided in multiple sizes of posterior augments, which helps me preserve bone. The wedge-augmented implant design minimizes reaming when correcting glenoid deformity,3 and the porous cage peg design provides excellent initial fixation,” said Dr. Grey.1-3*

Another design surgeon, Thomas Wright, MD, of the University of Florida (Gainesville, Fla.), said, “Exactech is committed to innovation, and this new glenoid implant highlights their intense focus on designing new devices that address unmet clinical needs, like aseptic glenoid loosening, offering the potential for better outcomes for my patients. This new implant is the next generation of a well-proven design with more than 11 years of clinical use, and I am proud to help Exactech bring this important new device to the U.S. market.”

The Laser Cage Glenoid is in pilot launch in the United States. In addition to Drs. Grey, Schoch, and Wright, the surgeon design team includes Stephen Brockmeier, MD, of the University of Virginia Health System, Pierre-Henri Flurin, MD, of the Surgical Clinic of Bordeaux, and Joseph Zuckerman, MD, of the NYU Langone Orthopedic Hospital.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and Twitter.

1Testing on file.*

2Friedman, R. et al. Clinical and Radiographic Comparison of a Hybrid Cage Glenoid to a Cemented Polyethylene Glenoid in Anatomic Total Shoulder Arthroplasty. J Shoulder Elbow Surg. 2019 Dec;28(12):2308-2316.

3Roche, C. et al. Biomechanical Impact of Posterior Glenoid Wear on Anatomic Total Shoulder Arthroplasty. Bulletin for the Hospital for Joint Diseases. 71(2):S5-11. 2013.*

*In vitro (bench) test results may not necessarily be indicative of clinical performance.

Contacts

Media Contact
Samantha DiVirgilio
Marketing Communications Manager
Samantha.divirgilio@exac.com

Exactech

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI

Release Versions

Contacts

Media Contact
Samantha DiVirgilio
Marketing Communications Manager
Samantha.divirgilio@exac.com

More News From Exactech

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe. “We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innov...
Back to Newsroom